Stocks of Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded higher last session on Wall Street, down -0.27% to $29.12.
According to the data, Walgreens Boots Alliance Inc. (NASDAQ:WBA) has 18 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $41.00 and a low of $27.00, we find $31.50. Given the previous closing price of $29.20, this indicates a potential upside of 7.88 percent. WBA stock price is now -5.63% away from the 50-day moving average and -16.60% away from the 200-day moving average. The market capitalization of the company currently stands at $25.60B.
A total of 14 analysts have issued a hold rating and 1 have given it a buy rating. Brokers who have rated the stock have averaged $32.14 as their price target over the next twelve months.
With the price target reduced from $37 to $27, Morgan Stanley maintained Underweight rating for Walgreens Boots Alliance Inc. (NASDAQ: WBA).
In other news, DRISCOLL JOHN PATRICK, EVP, Pres. U.S. Healthcare bought 5,172 shares of the company’s stock on Jun 30. The stock was bought for $146,984 at an average price of $28.42. Upon completion of the transaction, the EVP, Pres. U.S. Healthcare now directly owns 59,050 shares in the company, valued at $1.72 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 15, 10% Owner Walgreens Boots Alliance, Inc. sold 275,984 shares of the business’s stock. A total of $50,000,021 was realized by selling the stock at an average price of $181.17. This leaves the insider owning 33,090,404 shares of the company worth $963.59 million. Insiders disposed of 163,929 shares of company stock worth roughly $4.77 million over the past 1 year. A total of 0.30% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in WBA stock. A new stake in Walgreens Boots Alliance Inc. shares was purchased by PUTNAM INVESTMENTS LLC during the first quarter worth $9,144,000. COBALT CAPITAL MANAGEMENT, INC. invested $5,242,000 in shares of WBA during the first quarter. In the first quarter, BAYESIAN CAPITAL MANAGEMENT, LP acquired a new stake in Walgreens Boots Alliance Inc. valued at approximately $3,893,000. AIGEN INVESTMENT MANAGEMENT, LP acquired a new stake in WBA for approximately $3,830,000. INVENOMIC CAPITAL MANAGEMENT LP purchased a new stake in WBA valued at around $3,808,000 in the second quarter. In total, there are 1,647 active investors with 59.80% ownership of the company’s stock.
Monday’s opening bell rang with an opening price of $29.11 for Walgreens Boots Alliance Inc. (NASDAQ: WBA). During the past 12 months, Walgreens Boots Alliance Inc. has had a low of $28.14 and a high of $42.29. As of last week, the company has a debt-to-equity ratio of 0.61, a current ratio of 0.60, and a quick ratio of 0.30. The fifty day moving average price for WBA is $30.80 and a two-hundred day moving average price translates $34.90 for the stock.
The latest earnings results from Walgreens Boots Alliance Inc. (NASDAQ: WBA) was released for May, 2023. The net profit margin was -2.40% and return on equity was -15.10% for WBA. The company reported revenue of $35.41 billion for the quarter, compared to $32.6 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.64 percent.
Moreover, the firm recently paid out its quarterly dividend on 09/12/2023. Investors who held shares on 08/21/2023 were paid a $0.48 dividend. On an annualized basis, this represents a $1.92 dividend and a 6.59% percent yield. There was an ex-dividend date of 08/18/2023 for this dividend. In terms of dividend payout ratio, WBA is presently at 38.21%.
Walgreens Boots Alliance Inc.(WBA) Company Profile
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
